COMMUNIQUÉS West-GlobeNewswire

Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates
05/11/2026
Continued progress toward starting SC451 Phase 1/2 trial in type 1 diabetes Continued progress toward starting clinical study for SG293 in non-Hodgkin lymphoma Announced follow-on publication in The New England Journal [...]
FocalTherics™ Reports Third Quarter 2026 Financial Results
05/11/2026
45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date FocalTherics™ Reports Third Quarter 2026 Financial Results 45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date AUSTIN, [...]
ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance, Expecting Results at the High End of Range
05/11/2026
SAN CLEMENTE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
CAMP4 Reports Third Quarter 2026 Financial Results and Corporate Highlights
05/11/2026
Received authorization in the United Kingdom and European Union to expand global first-in-human ASCEND Phase 1/2 clinical trial of CMP-002 in patients with SYNGAP1-related disorder, adding to clearances in Australia and [...]
Rezolute Reports First Quarter Fiscal 2027 Financial Results and Provides Business Update
05/11/2026
REDWOOD CITY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or the Company), a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by [...]
SkinHealth Systems Reports Third Quarter 2026 Financial Results
05/11/2026
LONG BEACH, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial®, today announced financial results for the third [...]
CVRx Reports Third Quarter 2026 Financial and Operating Results
05/11/2026
MINNEAPOLIS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
LB Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
05/11/2026
Strengthened leadership with the appointment of Susan G. Kozauer, M.D., as Chief Medical Officer and Joseph Miller as Chief Financial Officer On track for topline data readout from the pivotal Phase 3 NOVA-2 trial of LB [...]
MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares
05/11/2026
MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares YAVNE, Israel, November 5, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a global leader in next-generation [...]
Vaxart Provides Business Update and Reports Third Quarter 2026 Financial Results
05/11/2026
Topline data from 400-person sentinel safety cohort and approximately 5,000 patients in main cohort Phase 2b COVID-19 trial anticipated by mid-year 2027 Expanded intellectual property portfolio with new European patent [...]
AVITA Medical Reports Third Quarter Results
05/11/2026
Delivers Strong Q3 With 53% Year-Over-Year Revenue Growth Raises Full Year 2026 Revenue Guidance VALENCIA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic [...]
The Joint Corp. Reports Third Quarter 2026 Financial Results
05/11/2026
- Revenue Increases to $13.6 Million - - Net Income from Continuing Operations Increases by $1.2 Million to $1.5 Million and Adjusted EBITDA From Continuing Operations Increases by $0.9 Million to $2.3 Million - - [...]
Sight Sciences to Present at Two Upcoming Investor Conferences
05/11/2026
MENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
ASHA Responds to New Speech-Language Pathology Treatment Codes in 2027 Medicare Physician Fee Schedule
05/11/2026
Throughout the development of this coding change, ASHA’s advocacy prioritized ensuring that speech-language pathology services are accurately described, appropriately valued, and supported by payment policies that [...]
EmblemHealth Distributes More Than 62,000 Bags of Food as Food Insecurity Continues To Grow Across New York City
05/11/2026
EmblemHealth’s Community Food Security Program reaches New Yorkers through nearly 400 events and a network of 115 food access partners PHOTO: EmblemHealth staff assist community members at a Neighborhood Care event [...]
Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results
05/11/2026
Trial met primary endpoint with a statistically significant reduction in microglial activation on TSPO PET (p=0.0168) Intranasal foralumab is the first non-invasive anti-CD3 therapy that has shown a favorable safety and [...]
What Published Human Trials Show About a Postbiotic in Women Ages 40 to 55
05/11/2026
Three peer-reviewed studies behind the two ingredients in Calroy Health Sciences’ Selentra HP™ measured inflammatory markers, skin health, and bone mineral density in women during and after the menopause transition. [...]
Scipher Medicine and Grupo Amarey Announce First PrismRA® Patient Tests Completed in Colombia
05/11/2026
DURHAM, N.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Scipher Medicine, a leading precision medicine company, today announced that the first patient tests under its strategic partnership with Grupo Amarey have been [...]
GENFIT Reports Third Quarter 2026 Financial Information and Provides Corporate Update
05/11/2026
Cash and cash equivalents of €95.6 million as of September 30, 2026; expected to fund the Company beyond 2028, with continued revenue growth and disciplined spending thereafter expected to drive GENFIT toward [...]

Pages